期刊文献+

雷帕霉素对肾小球系膜细胞增殖及凋亡的影响 被引量:2

Effect of rapamycin on the proliferation and apoptosis of glomerular mesangial cells
原文传递
导出
摘要 目的观察不同浓度雷帕霉素对大鼠肾小球系膜细胞增殖及凋亡的影响,探讨其可能的作用机制。方法使用不同浓度雷帕霉素(1μg/L、2μg/L、4μg/L、8μg/L、16μg/L)处理大鼠肾小球系膜细胞,并设正常对照组。MTT法测不同浓度雷帕霉素干预24h、48h、72h后对细胞增殖的影响,并描记生长曲线。干预72h后,采用RT-PCR和Western印迹法分别检测各浓度雷帕霉素组细胞周期负调蛋白p27和p53的mRNA和蛋白表达变化;用流式细胞计量术检测各浓度雷帕霉素组细胞周期及凋亡率。结果小剂量雷帕霉素(1μg/L)对系膜细胞增殖即具有明显的抑制作用,停滞于G1期的细胞数明显增加,但对系膜细胞凋亡无明显影响。较大剂量雷帕霉素(8~16μg/L)能够明显增加肾小球系膜细胞凋亡。雷帕霉素能够增加肾小球系膜细胞p27、p53mRNA和蛋白表达,且呈剂量依赖性。结论雷帕霉素可能通过增加p27、p53表达抑制肾小球系膜细胞增殖和促进系膜细胞凋亡。 Objective To investigate the effect of different concentrations of rapamyein on the proliferation and apoptosis of glomerular mesangial cells (GMCs) and to investigate the mechanism. Methods GMCs were treated with different concentrations of rapamycin (1 νg/L, 2 μg/L, 4 μg/L, 8 μg/L, 16 μg/L). After treatment for 24 h, 48 h and 72 h, cell proliferation was assessed by MTT eolorimetric assay and the growth curve was traced. After treatment for 72 h, the cell cycle distribution and the apoptotic rate of GMCs in different concentrations of rapamycin were analyzed by flow cytometry. The effects of different concentrations of rapamycin on the mRNA and protein expression of p27 and p53 were detected by RT-PCR and Western blot respectively. Result The low dose of rapamycin (1 μg/L) could significantly inhibit the proliferation of GMCs and showed no effect on apoptosis. The high dose of rapamycin (8-16 μg/L) could significantly increase the apoptotic rate of GMCs. Rapamycin could increase the mRNA and protein expression of p27 and p53. Conclusion Rapamycin can inhibit GMCs proliferation and promote GMCs apoptosis by increasing the expression of p27 and p53.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2009年第11期849-852,共4页 Chinese Journal of Nephrology
基金 同家自然科学基金(30771014) 973项目(2007CB507400) 军队十一五课题(06MA265)
关键词 西罗莫司 肾小球系膜细胞 细胞增殖 细胞凋亡 Sirolimus Mesangial cells Cell proliferation Apoptosis
  • 相关文献

参考文献8

  • 1Chen JK, Chen J, Neilson EG, et al. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol, 2005, 16: 1384-1391.
  • 2Bonegio RG, Fuhro R, Wang Z, et al. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol, 2005, 16: 2063-2072.
  • 3Sakaguchi M, lsono M, Isshiki K, et al. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem Biophys Res Commun, 2006, 340:296-301.
  • 4Runyan CE, Schnaper HW, Poncelet AC. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3- stimulated mesangial cell collagen I expression in response to transforming growth lactor-β1. J Biol Chem, 2004, 279: 2632-2639.
  • 5Sugiyama H, Kashihara N, Makino H, et al. Apoptosis in glomerular sclerosis. Kidney lnt, 1996, 49:103-111.
  • 6Zindy F, Williams RT, Baudino TA, et al. Arf tumor suppressor promoter monito- latent oncogenic signals in vivo. Proc Natl Acad Sci USA, 2003, 100: 15930-15935.
  • 7Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell, 2006, 124: 471-484.
  • 8Thimmaiah KN, Easton J, Huang S, et al. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erkl -Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways. Cancer Res, 2003, 63: 364-374.

同被引文献28

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部